Market Trends of India Respiratory Devices Industry
Spirometers is Anticipated to Have Significant Growth Over the Forecast Period
The spirometer segment is anticipated to have significant growth in the Indian respiratory devices market over the forecast period. The spirometer is a medical device used to measure the proper functioning of the lungs. The volume of air inhaled and exhaled from the lungs is measured after maximum inhalation by the patient. A spirometer helps identify different respiratory diseases, such as bronchitis, chronic lung diseases that are obstructive, emphysema, asthma, and other breathing diseases, for screening in an occupational environment.
Furthermore, the increasing use of spirometers for the diagnosis of various respiratory diseases is expected to enhance segment growth. For instance, according to an article published by PubMed Central in August 2022, chronic obstructive pulmonary disease (COPD) diagnosis requires an airflow obstruction (AFO) using a spirometer, according to the global initiative for chronic obstructive lung disease guidelines, and spirometric testing is typically reserved for individuals with respiratory symptoms.
Additionally, the initiatives taken by the market players are expected to drive the growth of the market segment. For example, on World Chronic Obstructive Pulmonary Disease (COPD) Day in 2021, Cipla Limited launched Spirofy, India's first pneumotach-based portable, wireless spirometer.
Moreover, spirometers are also used to check the proper functioning of the lungs after treatment of pulmonary tuberculosis. For instance, according to an article published by the Indian Journal of Community Medicine in March 2022, spirometers were used to check the lung function impairment among patients suffering from tuberculosis in India. Hence, the increasing prevalence of tuberculosis in the country is also expected to enhance segment growth.
So, the uses of spirometers in India make it easier for patients to use this diagnostic tool, especially for asthma. This device is also being used more and more in hospitals and at home, so the segment is expected to grow over the next few years.
CPAP Devices Segment is Expected to Hold a Significant Share in the Market Over the Forecast Period
The major factors driving the growth of the segment are the rising geriatric population in the country, the increasing prevalence of sleep apnea, and increasing research and development activities with respect to CPAP devices.
CPAP or continuous positive airway pressure devices are used for the treatment of sleep apnea. The increasing prevalence of sleep apnea in the country is one of the major factors leading to the segment growth and as there is an association between old age and sleep apnea, the rising geriatric population is also expected to enhance the segment growth. For instance, according to a conference on 'dental sleep medicine' held in India in September 2021, it is estimated that around 4 million people, particularly the elderly and obese people are currently suffering from obstructive sleep apnea in India. The experts in the conference also stated CPAP devices are used for the treatment of sleep apnea and that if someone is waking up multiple times at night due to breathlessness and having a dry mouth in the morning with headache and fatigue all day, it might be due to obstructive sleep apnea.
Furthermore, key developments related to CPAP devices in the country are also leading to the growth of the segment. For instance, in June 2021, the Indian Institute of Technology, Ropar developed a power-free CPAP device called 'Jivan Vayu'. It is the Nation's one of the first such devices that functions even without electricity and is adapted to both kinds of oxygen generation units like O2 cylinders and oxygen pipelines in hospitals.
Hence, factors such as the increasing prevalence of sleep apnea, the rising geriatric population, and key developments related to CPAP devices in the country are expected to enhance the growth of the segment during the forecast period of the study.
